Dr. Abidi Pharmaceutical Laboratories (DABID) selling, general and administrative expenses
What makes up administrative, general and selling costs
Fundamental analysis of DABID on Fundai: DABID Fundamental Analysis, Mehr 1405: Profit Forecast and Valuation
- Ticker
- DABID
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Salaries and wages expense | 21,546,387 | 10,634,577 | 7,054,134 | 4,759,794 | 2,742,753 | 1,478,218 |
| Depreciation expense | 510,503 | 325,337 | 296,491 | 170,630 | 73,221 | 50,680 |
| Energy expense (water, electricity, gas and fuel) | 86,185 | 25,463 | 16,854 | 15,181 | 16,224 | 6,897 |
| Consumable materials expense | 582,766 | 282,318 | 251,752 | 132,262 | 59,990 | 38,470 |
| Advertising expense | 4,035,809 | 1,861,133 | 887,465 | 679,637 | 578,545 | 254,666 |
| Transportation and transfer expense | 649,770 | 285,930 | 268,495 | 194,023 | 128,707 | 92,026 |
| Other expenses | 2,708,930 | 1,809,384 | 1,476,446 | 1,058,160 | 526,105 | 544,989 |
| Total | 30,120,350 | 15,224,142 | 10,251,637 | 7,009,687 | 4,125,545 | 2,465,946 |
Reporting periods
34 periods are on file for this report, from the period ending 1396/09/30 to the period ending 1405/06/31.